Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose

NCT00700895 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

320

Enrollment

OTHER

Sponsor class

Conditions

Indications for Warfarin Therapy

Interventions

DRUG: Warfarin Sodium

Sponsor

National University Hospital, Singapore